LYN and acute myeloid leukemia: Intriguingly, significant higher expression levels of Lyn were observed in AML patients with favorable cytogenetics compared to intermediate or poor cytogenetic risk group according to MRC10 criteria [35] (Fig. 2a; Table 1).